Curie Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Curie Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9322
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biology and developmental biology, among others. It provides services in the area such as genetics and carcinogenesis, cell and tissue imaging, and others. It offers care, research and training services for detecting, treating and monitoring cancer. Curie Institute provides services in anesthesia, medicine, pediatrics, surgery, tumor biology, intensive care, pain and medical imaging, among others. The foundation offers masters, PhD and postdoctoral fellowship programmes, and other courses. Curie Institute is headquartered in Paris, France.

Curie Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9
Curie Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Curie Institute, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Institut Curie Enters into Agreement with Pierre Fabre 12
Roche and Institut Curie Enter into Agreement 13
Institut Curie Enters into Collaboration Agreement with Epidemium 14
Ignyta and Institut Curie Enter into Partnership 15
Bristol-Myers Squibb Enters into Co-Development Agreement with Institut Curie 16
Celyad Enters into Partnership with Institut Curie 17
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 18
Curie-Cancer Partners with Inventiva 19
Institut Curie Extends Research Agreement with Servier 20
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 21
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 22
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 23
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 24
Licensing Agreements 25
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 25
Theravectys Enters into Licensing Agreement with Institut Curie 26
Abbott Molecular Enters into Licensing Agreement with Institut Curie 27
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 28
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 29
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 30
Curie Institute – Key Competitors 31
Curie Institute – Key Employees 32
Curie Institute – Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Strategy And Business Planning 34
Sep 17, 2018: Institut Curie announces creation of Honing Biosciences 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Curie Institute, Pharmaceuticals & Healthcare, Key Facts 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9
Curie Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institut Curie Enters into Agreement with Pierre Fabre 12
Roche and Institut Curie Enter into Agreement 13
Institut Curie Enters into Collaboration Agreement with Epidemium 14
Ignyta and Institut Curie Enter into Partnership 15
Bristol-Myers Squibb Enters into Co-Development Agreement with Institut Curie 16
Celyad Enters into Partnership with Institut Curie 17
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 18
Curie-Cancer Partners with Inventiva 19
Institut Curie Extends Research Agreement with Servier 20
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 21
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 22
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 23
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 24
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 25
Theravectys Enters into Licensing Agreement with Institut Curie 26
Abbott Molecular Enters into Licensing Agreement with Institut Curie 27
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 28
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 29
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 30
Curie Institute, Key Competitors 31
Curie Institute, Key Employees 32

List of Figures
Curie Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Curie Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hudbay Minerals Inc:企業の戦略・SWOT・財務分析
    Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Hudbay Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Canbriam Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Canbriam Energy Inc (Canbriam) is an oil and gas exploration company that offers finding and developing liquids rich natural gas resources. The company develops liquids rich natural gas resources in the Western Canadian Sedimentary Basin. It owns and operates oil and gas producing properties …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hunt Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Hunt Oil Co (Hunt Oil), a subsidiary Hunt Consolidated, Inc., is an independent upstream company. It carries out exploration, production and development of oil and natural gas. In the US, it has acreage and active programs in the Williston Basin (Bakken) of North Dakota, the Permian Basin of …
  • Henry Schein Inc (HSIC)-製薬・医療分野:企業M&A・提携分析
    Summary Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It offers generic and branded pharmaceutica …
  • Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報
    Summary Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, O …
  • Arrow Energy Pty Ltd:企業の戦略的SWOT分析
    Arrow Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Oswaldo Cruz Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research and development in biological sciences. It offers research programs and technological development projects in vaccines production, medications, drugs, reagents and diagnostic kits. The foundation provides research in experiment …
  • Great Western Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Galilee Energy Ltd (GLL):企業の財務・戦略的SWOT分析
    Summary Galilee Energy Ltd (Galilee) is a mining and minerals exploration and development company that offer exploration and development services. The company acquires, explores, produces, and develops coal seam gas in the Galilee Basin near Longreach in Queensland. It offers projects such as ATP799 …
  • Volex plc (VLX):企業の財務・戦略的SWOT分析
    Volex plc (VLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Genetic Analysis AS:医療機器:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Imperial Energy Ltd:企業の戦略的SWOT分析
    Imperial Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • LG Electronics, Inc.:戦略・SWOT・企業財務分析
    LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gilead Sciences, Inc.:企業の戦略・SWOT・財務情報
    Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務分析
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • KeyCorp (KEY):電力:M&Aディール及び事業提携情報
    Summary KeyCorp (KeyCorp) is a bank holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services through its principle subsidiary, KeyBank Nat …
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆